The maker of Wegovy and Ozempic is now Europe's most valuable company
Novo Nordisk has overtaken LVMH as Europe's most valuable company, with soaring demand for its weight-loss drugs driving up its market capitalization, while LVMH has faced setbacks due to the slowing Chinese economy and a drop in stock over the past six months.